These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 3283776
1. The haemorheological and antithrombotic potential of pentoxifylline ('Trental'): a review. Schönharting M, Musikić P, Müller R. Pharmatherapeutica; 1988; 5(3):159-69. PubMed ID: 3283776 [Abstract] [Full Text] [Related]
2. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline. Müller R, Lebrach F. Pharmatherapeutica; 1980; 2(6):372-9. PubMed ID: 7001492 [Abstract] [Full Text] [Related]
3. Pentoxifylline -- a biomedical profile. Müller R. J Med; 1979; 10(5):307-29. PubMed ID: 393789 [Abstract] [Full Text] [Related]
4. The effect of pentoxifylline in septic shock--new pharmacologic aspects of an established drug. Schönharting MM, Schade UF. J Med; 1989; 20(1):97-105. PubMed ID: 2651550 [Abstract] [Full Text] [Related]
5. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects. Reilly DT, Quinton DN, Barrie WW. N Z Med J; 1987 Jul 22; 100(828):445-7. PubMed ID: 3330188 [Abstract] [Full Text] [Related]
9. Mechanism of the potentiation of thrombolysis by pentoxifylline (Trental). Ambrus JL, Ambrus CM, Mahfzah M, Markus JA, Klein E, Gastpar H. J Med; 1987 Jul 22; 18(5-6):265-76. PubMed ID: 3505256 [Abstract] [Full Text] [Related]
12. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline. Ott E, Lechner H. Ric Clin Lab; 1981 Jul 22; 11 Suppl 1():253-6. PubMed ID: 7188113 [Abstract] [Full Text] [Related]
13. Haemorheology and cerebrovascular disease: multifunctional approach with pentoxifylline. Müller R, Lehrach F. Curr Med Res Opin; 1981 Jul 22; 7(4):253-63. PubMed ID: 7014106 [Abstract] [Full Text] [Related]
14. [Effect of hexobendine and pentoxifylline on the viscosity of erythrocyte suspension]. Winkler R, Moser M. Wien Klin Wochenschr; 1983 Mar 18; 95(6):209-13. PubMed ID: 6880203 [Abstract] [Full Text] [Related]
15. [New aspects of the pharmacology of pentoxifylline]. Lenoble Giovannangeli M. J Mal Vasc; 1989 Mar 18; 14 Suppl A():35-41. PubMed ID: 2654314 [Abstract] [Full Text] [Related]
16. Pentoxifylline therapy in dermatology. A review of localized hyperviscosity and its effects on the skin. Ely H. Dermatol Clin; 1988 Oct 18; 6(4):585-608. PubMed ID: 3067918 [Abstract] [Full Text] [Related]
17. Filtrability investigations with red blood cell (RBC) suspensions: effects of different blood components and pentoxifylline on RBC flow rate. Seiffge D, Kiesewetter H. Ric Clin Lab; 1981 Oct 18; 11 Suppl 1():117-23. PubMed ID: 7188104 [Abstract] [Full Text] [Related]
18. [Indications for using trental in the initial manifestations of inadequate blood supply to the brain]. Eninia GI, Egere DA, Robule VKh, Maĭore IKh. Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Oct 18; 86(1):50-2. PubMed ID: 3953193 [Abstract] [Full Text] [Related]
19. On the therapy of disturbances of blood fluidity. Mueller R. Angiology; 1985 Apr 18; 36(4):226-34. PubMed ID: 3896041 [Abstract] [Full Text] [Related]
20. Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions. Leonhardt H, Grigoleit HG. Naunyn Schmiedebergs Arch Pharmacol; 1977 Sep 18; 299(2):197-200. PubMed ID: 909613 [Abstract] [Full Text] [Related] Page: [Next] [New Search]